Calamos Advisors’s United States Antimony UAMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$445K Sell
61,310
-73,162
-54% -$662K ﹤0.01% 840
2026
Q1
$1.17M Buy
134,472
+14,882
+12% +$130K ﹤0.01% 748
2025
Q4
$600K Sell
119,590
-25,933
-18% -$204K ﹤0.01% 742
2025
Q3
$902K Buy
145,523
+18,374
+14% +$76.8K ﹤0.01% 716
2025
Q2
$277K Buy
127,149
+17,992
+16% +$51K ﹤0.01% 797
2025
Q1
$240K Buy
+109,157
New +$189K ﹤0.01% 789

Other funds holding UAMY

Calamos Advisors's UAMY Position: Q2 2026 in Review

Calamos Advisors reduced its United States Antimony (UAMY) stake by 54% in Q2 2026, selling an estimated $662K and leaving 61,310 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Calamos Advisors first reported a position in UAMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.17M in Q1 2026. 107 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

  • Calamos Advisors held 61,310 shares of United States Antimony worth $445K as of Q2 2026.
  • Calamos Advisors sold 73,162 United States Antimony shares in Q2 2026, an estimated $662K.
  • United States Antimony made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #840 holding.
  • Calamos Advisors first reported a position in United States Antimony in Q1 2025 and has held it in 6 quarters since.
  • Calamos Advisors's United States Antimony position peaked at $1.17M in Q1 2026.
  • 107 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.